H

Harrow Health

HROW

24.600
USD
-1.21
(-4.69%)
Market Closed
Volume
20,183
EPS
0
Div Yield
0
P/E
-47
Market Cap
1,598,861,457
Related Instruments
B
BYD
-3.090
(-5.08%)
57.780 USD
C
CZR
-2.550
(-6.39%)
37.380 USD
G
GLPI
-1.110
(-2.21%)
49.090 USD
L
LVS
-1.210
(-3.05%)
38.450 USD
M
MCRI
-3.615
(-4.62%)
74.665 USD
M
MGM
-5.690
(-13.24%)
37.290 USD
P
PENN
-1.050
(-5.26%)
18.920 USD
V
VICI
0.070
(0.22%)
31.350 USD
W
WYNN
-4.150
(-5.01%)
78.680 USD
News

Title: Harrow

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sightby making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.